1. Real-World Azacitidine use does not Replicate AZA-001 Results in Higher-Risk MDS/Low-Blast Count AML: Audit of 1101 Patients in Ontario, Canada. (April 2017) Authors: Mozessohn, L.; Cheung, M.; Fallahpour, S.; Gill, T.; Maloul, A.; Zhang, L.; Lau, O.; Buckstein, R. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗